Table 6.
mouse strain | development/ phenotype |
apoptotic/ non-apoptotic/unspecified effect | reference | |
---|---|---|---|---|
Casp-14 −/− | Swiss Webster X 129 | shinier and more lichenified skin | abnormal cleavage of profilaggrin | [266] |
Casp-14 −/− | Swiss Webster X 129 | reduced epidermal barrier | defect in the terminal filaggrin degradation | [260] |
Casp-14 −/− | Swiss Webster X 129 | predisposed parakeratosis | abnormal differentiation and the maintenance of stratum corneum | [268] |
Casp-14 −/− | Swiss Webster X 129 | enhanced antibacterial response | imbalance of the skin-resident bacterial communities | [269] |